284 related articles for article (PubMed ID: 10772435)
1. Epididymo-orchitis following intravesical bacillus Calmette-Guérin therapy.
Menke JJ; Heins JR
Ann Pharmacother; 2000 Apr; 34(4):479-82. PubMed ID: 10772435
[TBL] [Abstract][Full Text] [Related]
2. Granulomatous epididymo-orchitis, a rare complication of intravesical bacillus Calmette-Guérin therapy for urothelial cancer.
Harving SS; Asmussen L; Roosen JU; Hermann G
Scand J Urol Nephrol; 2009; 43(4):331-3. PubMed ID: 19396724
[TBL] [Abstract][Full Text] [Related]
3. Tuberculous epididymo-orchitis following intravesical BCG for superficial bladder cancer.
Bulbul MA; Hijaz A; Beaini M; Araj GF; Tawil A
J Med Liban; 2002; 50(1-2):67-9. PubMed ID: 12841318
[TBL] [Abstract][Full Text] [Related]
4. Epididymo-orchitis and Reiter's disease. Two infrequent complications after intravesical bacillus Calmette-Guérin therapy.
Hansen CP; Mortensen S
Scand J Urol Nephrol; 1997 Jun; 31(3):317-8. PubMed ID: 9249904
[TBL] [Abstract][Full Text] [Related]
5. Tuberculous epididymo-orchitis after intravesical BCG therapy for superficial bladder carcinoma: sonographic findings.
Salvador R; Vilana R; Bargalló X; Araque X; Nicolau C
J Ultrasound Med; 2007 May; 26(5):671-4. PubMed ID: 17460010
[No Abstract] [Full Text] [Related]
6. Preoperative diagnosis of bilateral tuberculous epididymo-orchitis following intravesical Bacillus Calmette-Guerin therapy for superficial bladder carcinoma.
Muttarak M; Lojanapiwat B; Chaiwun B; Wudhikarn S
Australas Radiol; 2002 Jun; 46(2):183-5. PubMed ID: 12060159
[TBL] [Abstract][Full Text] [Related]
7. Tuberculous epididymitis following intravesical Bacillus Calmette-Guérin immunotherapy.
Hoag N; Pommerville PJ; Kibsey PC; Cavers DJ; Eddy RJ
Can J Urol; 2009 Apr; 16(2):4589-91. PubMed ID: 19364433
[TBL] [Abstract][Full Text] [Related]
8. Haemophagocytic syndrome after intravesical bacille Calmette-Guérin instillation.
Misra S; Gupta A; Symes A; Duncan J
Scand J Urol; 2014 Jun; 48(3):328-30. PubMed ID: 24070063
[TBL] [Abstract][Full Text] [Related]
9. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy.
Ozbakkaloglu B; Tünger O; Sürücüoglu S; Lekili M; Kandiloglu AR
Int Urol Nephrol; 1999; 31(1):49-53. PubMed ID: 10408303
[TBL] [Abstract][Full Text] [Related]
10. Epididymo-orchitis developing as a late manifestation of intravesical bacillus Calmette-Guerin therapy and masquerading as a primary testicular malignancy: a report of 2 cases.
Truelson T; Wishnow KI; Johnson DE
J Urol; 1992 Nov; 148(5):1534-5. PubMed ID: 1433567
[TBL] [Abstract][Full Text] [Related]
11. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
[TBL] [Abstract][Full Text] [Related]
12. "BCGitis": A rare case of tuberculous epididymo-orchitis following intravesical Bacillus Calmette-Guérin therapy.
Demers V; Pelsser V
J Radiol Case Rep; 2012 Nov; 6(11):16-21. PubMed ID: 23372864
[TBL] [Abstract][Full Text] [Related]
13. Late occurrence of bilateral tuberculous-like epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma.
Falkensammer C; Gozzi C; Hager M; Maier H; Bartsch G; Höltl L; Rehder P
Urology; 2005 Jan; 65(1):175. PubMed ID: 15667898
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
[TBL] [Abstract][Full Text] [Related]
15. Epididymo-orchitis caused by intravesically instillated bacillus Calmette-Guérin: genetically proven using a multiplex polymerase chain reaction method.
Harada H; Seki M; Shinojima H; Miura M; Hirano T; Togashi M
Int J Urol; 2006 Feb; 13(2):183-5. PubMed ID: 16563148
[TBL] [Abstract][Full Text] [Related]
16. Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guérin therapy.
Heiner JG; Terris MK
Urol Oncol; 2008; 26(2):137-40. PubMed ID: 18312931
[TBL] [Abstract][Full Text] [Related]
17. Xanthogranulomatous orchitis in a patient with a history of instrumentation and bacillus Calmette-Guérin therapy.
Hill JR; Gorgon G; Wahl SJ; Armenakas NA; Fracchia JA
Urology; 2008 Aug; 72(2):461.e11-3. PubMed ID: 18336889
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and management of adverse events occuring during BCG therapy for non-muscle invasive bladder cancer (NMIBC): review of the Cancer Committee of the French Association of Urology].
Neuzillet Y; Rouprêt M; Wallerand H; Pignot G; Larré S; Irani J; Davin JL; Moreau JL; Soulié M; Pfister C;
Prog Urol; 2012 Dec; 22(16):989-98. PubMed ID: 23178094
[TBL] [Abstract][Full Text] [Related]
19. Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma.
Cugati S; Gilhotra JS; Lake S; Gordon DL
Clin Exp Ophthalmol; 2014 Jul; 42(5):494-5. PubMed ID: 24372891
[No Abstract] [Full Text] [Related]
20. Small bladder and multiple urethral recurrences after intravesical instillation of bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder.
Manasia P; Alcaraz A; Cetina A; Alcover J
J Urol; 2001 Feb; 165(2):529-30. PubMed ID: 11176420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
